Osteoblast-Chondrocyte Interactions in Osteoarthritis

Por Findlay, David M., Atkins, Gerald J
Publicado em 2014

Role of polyethylene particles in peri-prosthetic osteolysis: A review

Por Atkins, Gerald J, Haynes, David R, Howie, Donald W, Findlay, David M
Publicado em 2011

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway

Por Wijenayaka, Asiri R., Kogawa, Masakazu, Lim, Hui Peng, Bonewald, Lynda F., Findlay, David M., Atkins, Gerald J.
Publicado em 2011

Characterization of drug-release kinetics in trabecular bone from titania nanotube implants

Por Aw, Moom Sinn, Khalid, Kamarul A, Gulati, Karan, Atkins, Gerald J, Pivonka, Peter, Findlay, David M, Losic, Dusan
Publicado em 2012

Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo

Por Kato, Naoki, Matsumoto, Masahito, Kogawa, Masakazu, Atkins, Gerald J, Findlay, David M, Fujikawa, Takahiko, Oda, Hiromi, Ogata, Masato
Publicado em 2013

Sclerostin Is a Locally Acting Regulator of Late-Osteoblast/Preosteocyte Differentiation and Regulates Mineralization Through a MEPE-ASARM-Dependent Mechanism

Por Atkins, Gerald J, Rowe, Peter S, Lim, Hui P, Welldon, Katie J, Ormsby, Renee, Wijenayaka, Asiri R, Zelenchuk, Lesya, Evdokiou, Andreas, Findlay, David M
Publicado em 2011

Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer...

Por Zysk, Aneta, DeNichilo, Mark O., Panagopoulos, Vasilios, Zinonos, Irene, Liapis, Vasilios, Hay, Shelley, Ingman, Wendy, Ponomarev, Vladimir, Atkins, Gerald, Findlay, David, Zannettino, Andrew, Evdokiou, Andreas
Publicado no Cancer Lett (2016)

HYPOXIA-ACTIVATED PRO-DRUG TH-302 EXHIBITS POTENT TUMOUR SUPPRESSIVE ACTIVITY AND COOPERATES WITH CHEMOTHERAPY AGAINST OSTEOSARCOMA

Por Liapis, Vasilios, Labrinidis, Agatha, Zinonos, Irene, Hay, Shelley, Ponomarev, Vladimir, Panagopoulos, Vasilios, DeNichilo, Mark, Ingman, Wendy, Atkins, Gerald J., Findlay, David M., Zannettino, Andrew CW., Evdokiou, Andreas
Publicado no Cancer Lett (2014)

TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis

Por Dharmapatni, Anak ASSK, Smith, Malcolm D, Crotti, Tania N, Holding, Christopher A, Vincent, Cristina, Weedon, Helen M, Zannettino, Andrew CW, Zheng, Timothy S, Findlay, David M, Atkins, Gerald J, Haynes, David R
Publicado em 2011

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models

Por Liapis, Vasilios, Zinonos, Irene, Labrinidis, Agatha, Hay, Shelley, Ponomarev, Vladimir, Panagopoulos, Vasilios, Zysk, Aneta, DeNichilo, Mark, Ingman, Wendy, Atkins, Gerald J., Findlay, David M., Zannettino, Andrew C. W., Evdokiou, Andreas
Publicado no Cancer Med (2016)

Apo2L/TRAIL Inhibits Tumor Growth and Bone Destruction in a Murine Model of Multiple Myeloma

Por Labrinidis, Agatha, Diamond, Peter, Martin, Sally, Hay, Shelley, Liapis, Vasilios, Zinonos, Irene, Sims, Natalie A., Atkins, Gerald J., Vincent, Cristina, Ponomarev, Vladimir, Findlay, David M., Zannettino, Andrew C.W., Evdokiou, Andreas
Publicado no Clin Cancer Res (2009)

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma

Por Liapis, Vasilios, Zysk, Aneta, DeNichilo, Mark, Zinonos, Irene, Hay, Shelley, Panagopoulos, Vasilios, Shoubridge, Alexandra, Difelice, Christopher, Ponomarev, Vladimir, Ingman, Wendy, Atkins, Gerald J., Findlay, David M., Zannettino, Andrew C. W., Evdokiou, Andreas
Publicado no Cancer Med (2017)

A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway

Por Bhattacharjee, Mitali, Raju, Rajesh, Radhakrishnan, Aneesha, Nanjappa, Vishalakshi, Muthusamy, Babylakshmi, Singh, Kamlendra, Kuppusamy, Dheebika, Lingala, Bhavya Teja, Pan, Archana, Mathur, Premendu Prakash, Harsha, H. C., Prasad, T. S. Keshava, Atkins, Gerald J., Pandey, Akhilesh, Chatterjee, Aditi
Publicado em 2012

Molecular Profiling of Giant Cell Tumor of Bone and the Osteoclastic Localization of Ligand for Receptor Activator of Nuclear Factor κB

Por Morgan, Teresa, Atkins, Gerald J., Trivett, Melanie K., Johnson, Sandra A., Kansara, Maya, Schlicht, Stephen L., Slavin, John L., Simmons, Paul, Dickinson, Ian, Powell, Gerald, Choong, Peter F.M., Holloway, Andrew J., Thomas, David M.
Publicado em 2005

The Paired-box Homeodomain Transcription Factor Pax6 Binds to the Upstream Region of the TRAP Gene Promoter and Suppresses Receptor Activator of NF-κB Ligand (RANKL)-induced Osteoc...

Por Kogawa, Masakazu, Hisatake, Koji, Atkins, Gerald J., Findlay, David M., Enoki, Yuichiro, Sato, Tsuyoshi, Gray, Peter C., Kanesaki-Yatsuka, Yukiko, Anderson, Paul H., Wada, Seiki, Kato, Naoki, Fukuda, Aya, Katayama, Shigehiro, Tsujimoto, Masafumi, Yoda, Tetsuya, Suda, Tatsuo, Okazaki, Yasushi, Matsumoto, Masahito
Publicado em 2013

Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer

Por ZINONOS, IRENE, LUO, KE-WANG, LABRINIDIS, AGATHA, LIAPIS, VASILIOS, HAY, SHELLEY, PANAGOPOULOS, VASILIOS, DENICHILO, MARK, KO, CHUN-HAY, YUE, GRACE GAR-LEE, LAU, CLARA BIK-SAN, INGMAN, WENDY, PONOMAREV, VLADIMIR, ATKINS, GERALD J., FINDLAY, DAVID M., ZANNETTINO, ANDREW C.W., EVDOKIOU, ANDREAS
Publicado em 2014

Calcitonin Receptor Plays a Physiological Role to Protect Against Hypercalcemia in Mice

Por Davey, Rachel A, Turner, Andrew G, McManus, Julie F, Chiu, WS Maria, Tjahyono, Francisca, Moore, Alison J, Atkins, Gerald J, Anderson, Paul H, Ma, Cathy, Glatt, Vaida, MacLean, Helen E, Vincent, Cristina, Bouxsein, Mary, Morris, Howard A, Findlay, David M, Zajac, Jeffrey D
Publicado em 2008